Drug Overdose Response Investigation (DORI) Data Collections

Forms and Documents

Document Name	Status
AttJ Generic DORI NCIPC Research Determination.pdf Supplementary Document	2017-12-13
Att. H. Data Collection Instruments – Fentanyl-heroin overdose deaths OH.pdf Supplementary Document	2017-12-12
Att. G Final Burden Memo GenDORI_Fentanyl-heroin overdose deaths OH.docx Supplementary Document	2017-12-12
Att. F Request Protocol GenDORI - Fentanyl-heroin overdose deaths OH.docx Supplementary Document	2017-12-12
Att. E Burden Memo Gen 1054 DORI.docx Supplementary Document	2017-12-12
Att. D_Request Protocol Template Gen 1054 DORI.docx Supplementary Document	2017-12-12
Att. C. Public Comment - 1054 DORI.pdf Supplementary Document	2017-12-12
Att. B. 60 Day FRN - 1054 DORI.pdf Supplementary Document	2017-12-12
SSB_1054_DORI_111517.docx Supporting Statement B	2017-12-12
SSA_1054_DORI_111517.docx Supporting Statement A	2017-12-12
AttaC5 NM_EpiIInstr_14ARR GenDORI.pdf Supplementary Document	2014-11-25
AttaC4 RI_IntervInstr_14ARR GenDORI.docx Supplementary Document	2014-11-25
AttaC3 RI_EpiInfoInstr_14ARR GenDORI.pdf Supplementary Document	2014-11-25
AttaC2_WVA_Instr_14ARR GenDORI.docx Supplementary Document	2014-11-25
AttaC1_PrevEpiAid_14ARR GenDORI.docx Supplementary Document	2014-11-25
AttaA_AuthLeg_14ARR GenDORI.docx Supplementary Document	2014-11-25

IC Document Collections

IC ID	Document Title	Status

ICR Details

OMB Control No: 0920-1054	ICR Reference No: 201711-0920-004
Status: Active	Previous ICR Reference No: 201411-0920-013
Agency/Subagency: HHS/CDC	Agency Tracking No: 0920-1054
Title: Drug Overdose Response Investigation (DORI) Data Collections
Type of Information Collection: Extension without change of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 01/29/2018
	Date Received in OIRA: 12/14/2017
Terms of Clearance: For any Gen ICs with statistical methods, a Part B will be submitted for review along with the Gen IC and template.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	01/31/2021	36 Months From Approved	03/31/2018
Responses	6,000	0	8,100
Time Burden (Hours)	3,000	0	4,050
Cost Burden (Dollars)	0	0	0

---

Abstract: State and local health authorities frequently call upon CDC's National Center for Injury Prevention and Control (NCIPC) to assist in their response to urgent public health problems resulting from drug use, misuse, abuse, and overdose. When called, NCIPC supports the states and local health authorities by conducting Drug Overdose Response Investigations (DORI), which entails a rapid and flexible epidemiological response. Urgent requests such as DORIs depend on the time and resources available, number of persons involved, and other circumstances unique to the urgent conditions at hand and usually involve the development of procedures, specific data collection instruments, and the collection of critical data. This request is for a new generic approval to conduct information collections during DORIs. A three-year clearance is requested to ensure: (1) rapid deployment data collection tools and (2) timely information collection of vital information. Of particular interest is response to increasing trends in, or changing characteristics of, overdose from prescription drugs (with a special interest in opioid analgesics such as oxycodone or methadone; benzodiazepines such as alprazolam) and/or illicit drugs (e.g., heroin). Specifically, this request covers investigative collections with the following aims: (1) To understand sudden increases in drug use and misuse associated with fatal and nonfatal overdoses; (2) to understand the drivers and risk factors associated with those trends; and (3) to identify the groups most affected. This will allow CDC to effectively advise states on recommended actions to control local epidemics. Thus, the ultimate goals of these collections are to minimize adverse health consequences, provide epidemiological data collection support to the states and, based on the findings from the investigation, appropriately assist with implementation of prevention and control measures. This submission is being made to extend the approval period for three additional years.

---

Authorizing Statute(s): US Code: 42 USC 241 Name of Law: Public Heath Service Act
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	82 FR 32705	07/17/2017
30-day Notice:	Federal Register Citation:	Citation Date:
	82 FR 58608	12/13/2017
Did the Agency receive public comments on this ICR? Yes

---

Number of Information Collection (IC) in this ICR: 0

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	6,000	8,100	0	-2,100	0	0
Annual Time Burden (Hours)	3,000	4,050	0	-1,050	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: Yes

Burden Reduction Due to: Miscellaneous Actions

Short Statement: Submission of 0920-1054 is an Extension of the Generic mechanism - Drug Overdose Response Investigation (DORI).

---

Annual Cost to Federal Government: $74,740

Does this IC contain surveys, censuses, or employ statistical methods? No

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 12/14/2017

---